Integrated ODM Bridgemedica operates as an end-to-end medical device development and manufacturing partner with ISO 13485:2003 and FDA registration, presenting a ready-made solution for companies seeking design, development, regulatory, and supply chain services under one roof.

Acquired Strength As a NN Life Sciences subsidiary since 2018, Bridgemedica leverages parent company resources, regulatory know-how, and established processes to de-risk projects, accelerate time to market, and provide scale advantages for device programs.

Compact Team Advantage with a lean team (11-50 employees) Bridgemedica offers focused expertise, agile communication, and personalized support for faster decision cycles, appealing to small to mid-size medtech firms seeking high-touch collaboration.

Regulatory Readiness The company emphasizes design control, compliance documentation tracking, ISO/QSR-aligned quality systems, and regulatory filings, creating opportunities with startups and established manufacturers aiming to streamline approvals and quality assurance.

Cost and Efficiency Focus By delivering concept-to-supply solutions and aiming to minimize hand-off risk, Bridgemedica targets improved device economics for clients, presenting a compelling value proposition for companies seeking cost-efficient development and manufacturing partnerships.